Lv2
170 积分 2023-04-19 加入
Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms
1天前
已完结
A single homogeneous assay for simultaneous measurement of bispecific antibody target binding
17天前
已完结
The impact of CD3 affinity-attenuation on T cell engaging bispecific antibodies: is it really that simple?
21天前
已完结
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning
21天前
已完结
Discovery and Characterization of RP03707: A Highly Potent and Selective KRAS G12D PROTAC
1个月前
已完结
A single homogeneous assay for simultaneous measurement of bispecific antibody target binding
1个月前
已完结
Targeting cancer with small molecule pan-KRAS degraders
1个月前
已完结
Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy
1个月前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
1个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
1个月前
已完结
皖公网安备34019202002308
